2018-2023 Global Addiction Treatment Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Addiction Treatment market for 2018-2023.
Drug addiction is a chronic, recurrent disease characterized by the uncontrolled application of an addictive drug. In recent years, the abuse of exogenous opioids (such as morphine and heroin) has become a serious social problem. It does not care about the physical and mental health of the abuser himself. It also has disastrous consequences for families and society. Opioid withdrawal is extremely difficult once it is abused.
Drug addiction is a chronic, recurrent brain disease that seriously damages health and causes enormous social problems. Relapse is one of the main characteristics of drug addiction, and it is also the main problem to be solved in the treatment of drug addiction. The high relapse rate is the biggest challenge facing drug addiction medicine.
Over the next five years, LPI(LP Information) projects that Addiction Treatment will register a 6.0% CAGR in terms of revenue, reach US$ 5020 million by 2023, from US$ 3540 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Addiction Treatment market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Other Substance Addiction Treatment
Segmentation by application:
Outpatient Treatment Center
Residential Treatment Center
Inpatient Treatment Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Cipla
Allergan
Alkermes
Pfizer
Orexo
GlaxoSmithKiline
Purdue Pharma
Mallinckrodt
Reckitt Benckiser
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Addiction Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Addiction Treatment market by identifying its various subsegments.
Focuses on the key global Addiction Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Addiction Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Addiction Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Addiction Treatment Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Addiction Treatment Consumption 2013-2023
2.1.2 Addiction Treatment Consumption CAGR by Region
2.2 Addiction Treatment Segment by Type
2.2.1 Alcohol Addiction Treatment
2.2.2 Tobacco/Nicotine Addiction Treatment
2.2.3 Tobacco/Nicotine Addiction Treatment
2.2.4 Other Substance Addiction Treatment
2.3 Addiction Treatment Consumption by Type
2.3.1 Global Addiction Treatment Consumption Market Share by Type (2013-2018)
2.3.2 Global Addiction Treatment Revenue and Market Share by Type (2013-2018)
2.3.3 Global Addiction Treatment Sale Price by Type (2013-2018)
2.4 Addiction Treatment Segment by Application
2.4.1 Outpatient Treatment Center
2.4.2 Residential Treatment Center
2.4.3 Inpatient Treatment Center
2.5 Addiction Treatment Consumption by Application
2.5.1 Global Addiction Treatment Consumption Market Share by Application (2013-2018)
2.5.2 Global Addiction Treatment Value and Market Share by Application (2013-2018)
2.5.3 Global Addiction Treatment Sale Price by Application (2013-2018)
3 Global Addiction Treatment by Players
3.1 Global Addiction Treatment Sales Market Share by Players
3.1.1 Global Addiction Treatment Sales by Players (2016-2018)
3.1.2 Global Addiction Treatment Sales Market Share by Players (2016-2018)
3.2 Global Addiction Treatment Revenue Market Share by Players
3.2.1 Global Addiction Treatment Revenue by Players (2016-2018)
3.2.2 Global Addiction Treatment Revenue Market Share by Players (2016-2018)
3.3 Global Addiction Treatment Sale Price by Players
3.4 Global Addiction Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Addiction Treatment Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Addiction Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Addiction Treatment by Regions
4.1 Addiction Treatment by Regions
4.1.1 Global Addiction Treatment Consumption by Regions
4.1.2 Global Addiction Treatment Value by Regions
4.2 Americas Addiction Treatment Consumption Growth
4.3 APAC Addiction Treatment Consumption Growth
4.4 Europe Addiction Treatment Consumption Growth
4.5 Middle East & Africa Addiction Treatment Consumption Growth
5 Americas
5.1 Americas Addiction Treatment Consumption by Countries
5.1.1 Americas Addiction Treatment Consumption by Countries (2013-2018)
5.1.2 Americas Addiction Treatment Value by Countries (2013-2018)
5.2 Americas Addiction Treatment Consumption by Type
5.3 Americas Addiction Treatment Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Addiction Treatment Consumption by Countries
6.1.1 APAC Addiction Treatment Consumption by Countries (2013-2018)
6.1.2 APAC Addiction Treatment Value by Countries (2013-2018)
6.2 APAC Addiction Treatment Consumption by Type
6.3 APAC Addiction Treatment Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Addiction Treatment by Countries
7.1.1 Europe Addiction Treatment Consumption by Countries (2013-2018)
7.1.2 Europe Addiction Treatment Value by Countries (2013-2018)
7.2 Europe Addiction Treatment Consumption by Type
7.3 Europe Addiction Treatment Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Addiction Treatment by Countries
8.1.1 Middle East & Africa Addiction Treatment Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Addiction Treatment Value by Countries (2013-2018)
8.2 Middle East & Africa Addiction Treatment Consumption by Type
8.3 Middle East & Africa Addiction Treatment Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Addiction Treatment Distributors
10.3 Addiction Treatment Customer
11 Global Addiction Treatment Market Forecast
11.1 Global Addiction Treatment Consumption Forecast (2018-2023)
11.2 Global Addiction Treatment Forecast by Regions
11.2.1 Global Addiction Treatment Forecast by Regions (2018-2023)
11.2.2 Global Addiction Treatment Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Addiction Treatment Forecast by Type
11.8 Global Addiction Treatment Forecast by Application
12 Key Players Analysis
12.1 Cipla
12.1.1 Company Details
12.1.2 Addiction Treatment Product Offered
12.1.3 Cipla Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Cipla News
12.2 Allergan
12.2.1 Company Details
12.2.2 Addiction Treatment Product Offered
12.2.3 Allergan Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Allergan News
12.3 Alkermes
12.3.1 Company Details
12.3.2 Addiction Treatment Product Offered
12.3.3 Alkermes Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Alkermes News
12.4 Pfizer
12.4.1 Company Details
12.4.2 Addiction Treatment Product Offered
12.4.3 Pfizer Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Pfizer News
12.5 Orexo
12.5.1 Company Details
12.5.2 Addiction Treatment Product Offered
12.5.3 Orexo Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Orexo News
12.6 GlaxoSmithKiline
12.6.1 Company Details
12.6.2 Addiction Treatment Product Offered
12.6.3 GlaxoSmithKiline Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 GlaxoSmithKiline News
12.7 Purdue Pharma
12.7.1 Company Details
12.7.2 Addiction Treatment Product Offered
12.7.3 Purdue Pharma Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Purdue Pharma News
12.8 Mallinckrodt
12.8.1 Company Details
12.8.2 Addiction Treatment Product Offered
12.8.3 Mallinckrodt Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Mallinckrodt News
12.9 Reckitt Benckiser
12.9.1 Company Details
12.9.2 Addiction Treatment Product Offered
12.9.3 Reckitt Benckiser Addiction Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Reckitt Benckiser News
13 Research Findings and Conclusion
